14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Tuesday, 7th May 2024 OTLK stock ended at $8.21. This is 3.41% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 7.10% from a day low at $8.17 to a day high of $8.75.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Outlook Therapeutics Inc. prices

Date Open High Low Close Volume
Mar 13, 2017 $2.93 $3.40 $2.92 $3.24 28 691
Mar 10, 2017 $2.99 $2.99 $2.74 $2.79 22 933
Mar 09, 2017 $2.61 $2.68 $2.45 $2.68 49 900
Mar 08, 2017 $2.68 $2.81 $2.61 $2.73 18 350
Mar 07, 2017 $2.75 $3.08 $2.56 $2.66 49 951
Mar 06, 2017 $3.10 $3.18 $2.40 $3.14 66 105
Mar 03, 2017 $3.14 $3.15 $2.81 $2.90 61 082
Mar 02, 2017 $3.15 $3.20 $3.11 $3.20 12 313
Mar 01, 2017 $3.21 $3.29 $3.15 $3.15 10 850
Feb 28, 2017 $3.52 $3.52 $3.19 $3.19 18 210
Feb 27, 2017 $3.31 $3.48 $3.25 $3.41 6 024
Feb 24, 2017 $3.36 $3.36 $3.23 $3.23 2 621
Feb 23, 2017 $3.21 $3.31 $3.18 $3.31 7 047
Feb 22, 2017 $3.30 $3.32 $3.25 $3.28 48 542
Feb 21, 2017 $3.36 $3.42 $3.29 $3.35 16 177
Feb 17, 2017 $3.52 $3.52 $3.37 $3.46 12 620
Feb 16, 2017 $3.77 $3.77 $3.28 $3.28 134 921
Feb 15, 2017 $3.47 $3.75 $3.45 $3.75 12 833
Feb 14, 2017 $3.49 $3.50 $3.38 $3.50 1 941
Feb 13, 2017 $3.45 $3.49 $3.39 $3.39 5 473
Feb 10, 2017 $3.43 $3.52 $3.35 $3.46 7 004
Feb 09, 2017 $3.39 $3.58 $3.38 $3.47 42 785
Feb 08, 2017 $3.36 $3.36 $3.20 $3.26 17 629
Feb 07, 2017 $3.22 $3.49 $3.22 $3.34 18 264
Feb 06, 2017 $3.29 $3.36 $3.25 $3.29 5 011
Click to get the best stock tips daily for free!

About Outlook Therapeutics Inc.

Outlook Therapeutics. Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice... OTLK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT